Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 19385

1.

Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma.

Vitiello M, Evangelista M, Di Lascio N, Kusmic C, Massa A, Orso F, Sarti S, Marranci A, Rodzik K, Germelli L, Chandra D, Salvetti A, Pucci A, Taverna D, Faita F, Gravekamp C, Poliseno L.

Oncogene. 2019 Jan 21. doi: 10.1038/s41388-019-0681-1. [Epub ahead of print]

PMID:
30664692
2.

Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis.

Luna Velez MV, Verhaegh GW, Smit F, Sedelaar JPM, Schalken JA.

Oncogene. 2019 Jan 21. doi: 10.1038/s41388-019-0696-7. [Epub ahead of print]

PMID:
30664691
3.

p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer.

Chang HW, Kim MR, Lee HJ, Lee HM, Kim GC, Lee YS, Nam HY, Lee M, Jang HJ, Lee KE, Lee JC, Byun Y, Kim SW, Kim SY.

Oncogene. 2019 Jan 21. doi: 10.1038/s41388-019-0697-6. [Epub ahead of print]

PMID:
30664690
4.

Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.

Das S, Nair RS, Mishra R, Sondarva G, Viswakarma N, Abdelkarim H, Gaponenko V, Rana B, Rana A.

Oncogene. 2019 Jan 21. doi: 10.1038/s41388-019-0690-0. [Epub ahead of print]

PMID:
30664689
5.

Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis.

Comito G, Iscaro A, Bacci M, Morandi A, Ippolito L, Parri M, Montagnani I, Raspollini MR, Serni S, Simeoni L, Giannoni E, Chiarugi P.

Oncogene. 2019 Jan 21. doi: 10.1038/s41388-019-0688-7. [Epub ahead of print]

PMID:
30664688
6.

KLF9-dependent ROS regulate melanoma progression in stage-specific manner.

Bagati A, Moparthy S, Fink EE, Bianchi-Smiraglia A, Yun DH, Kolesnikova M, Udartseva OO, Wolff DW, Roll MV, Lipchick BC, Han Z, Kozlova NI, Jowdy P, Berman AE, Box NF, Rodriguez C, Bshara W, Kandel ES, Soengas MS, Paragh G, Nikiforov MA.

Oncogene. 2019 Jan 21. doi: 10.1038/s41388-019-0689-6. [Epub ahead of print]

PMID:
30664687
7.

B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.

Köhler M, Ehrenfeld S, Halbach S, Lauinger M, Burk U, Reischmann N, Cheng S, Spohr C, Uhl FM, Köhler N, Ringwald K, Braun S, Peters C, Zeiser R, Reinheckel T, Brummer T.

Oncogene. 2019 Jan 18. doi: 10.1038/s41388-018-0663-8. [Epub ahead of print]

PMID:
30659267
8.

The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network.

Cheng M, Sheng L, Gao Q, Xiong Q, Zhang H, Wu M, Liang Y, Zhu F, Zhang Y, Zhang X, Yuan Q, Li Y.

Oncogene. 2019 Jan 18. doi: 10.1038/s41388-019-0683-z. [Epub ahead of print]

PMID:
30659266
9.

Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.

Kim I, Shin SH, Lee JE, Park JW.

Oncogene. 2019 Jan 18. doi: 10.1038/s41388-019-0676-y. [Epub ahead of print]

PMID:
30659265
10.

Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments.

Carrero I, Liu HC, Sikora AG, Milosavljevic A.

Oncogene. 2019 Jan 17. doi: 10.1038/s41388-018-0659-4. [Epub ahead of print]

PMID:
30655605
11.

The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.

De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A, Colombo MP, Di Virgilio F, Adinolfi E.

Oncogene. 2019 Jan 17. doi: 10.1038/s41388-019-0684-y. [Epub ahead of print]

PMID:
30655604
12.

Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma.

Kumar R, Njauw CN, Reddy BY, Ji Z, Rajadurai A, Klebanov N, Tsao H.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0632-2. [Epub ahead of print]

PMID:
30651601
13.

Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis.

Williams KC, Cepeda MA, Javed S, Searle K, Parkins KM, Makela AV, Hamilton AM, Soukhtehzari S, Kim Y, Tuck AB, Ronald JA, Foster PJ, Chambers AF, Leong HS.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0667-4. [Epub ahead of print]

PMID:
30651600
14.

Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.

Li M, Tang Y, Li Q, Xiao M, Yang Y, Wang Y.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0671-8. [Epub ahead of print]

PMID:
30651599
15.

Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.

Gunaratna RT, Santos A, Luo L, Nagi C, Lambertz I, Spier M, Conti CJ, Fuchs-Young RS.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0630-4. [Epub ahead of print]

PMID:
30651598
16.

Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repair.

Seoane M, Buhs S, Iglesias P, Strauss J, Puller AC, Müller J, Gerull H, Feldhaus S, Alawi M, Brandner JM, Eggert D, Du J, Thomale J, Wild PJ, Zimmermann M, Sternsdorf T, Schumacher U, Nollau P, Fisher DE, Horstmann MA.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0661-x. [Epub ahead of print]

PMID:
30651597
17.

ADAM10 mediates malignant pleural mesothelioma invasiveness.

Sépult C, Bellefroid M, Rocks N, Donati K, Gérard C, Gilles C, Ludwig A, Duysinx B, Noël A, Cataldo D.

Oncogene. 2019 Jan 16. doi: 10.1038/s41388-018-0669-2. [Epub ahead of print]

PMID:
30651596
18.

Proteasome inhibition boosts autophagic degradation of ubiquitinated-AGR2 and enhances the antitumor efficiency of bevacizumab.

Wang D, Xu Q, Yuan Q, Jia M, Niu H, Liu X, Zhang J, Young CY, Yuan H.

Oncogene. 2019 Jan 15. doi: 10.1038/s41388-019-0675-z. [Epub ahead of print]

PMID:
30647455
19.

APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.

Cannataro VL, Gaffney SG, Sasaki T, Issaeva N, Grewal NKS, Grandis JR, Yarbrough WG, Burtness B, Anderson KS, Townsend JP.

Oncogene. 2019 Jan 15. doi: 10.1038/s41388-018-0657-6. [Epub ahead of print]

PMID:
30647454
20.

ATDC mediates a TP63-regulated basal cancer invasive program.

Palmbos PL, Wang Y, Bankhead Iii A, Kelleher AJ, Wang L, Yang H, Ahmet ML, Gumkowski ER, Welling SD, Magnuson B, Leflein J, Lorenzatti Hiles G, Abel EV, Dziubinski ML, Urs S, Day ML, Ljungman ME, Simeone DM.

Oncogene. 2019 Jan 14. doi: 10.1038/s41388-018-0646-9. [Epub ahead of print]

PMID:
30643195

Supplemental Content

Loading ...
Support Center